Literature DB >> 8471047

Genetic variation of iron-induced uroporphyria in mice.

A G Smith1, J E Francis.   

Abstract

Iron overload causes inhibition of hepatic uroporphyrinogen decarboxylase (UROD) and uroporphyria in C57BL/10ScSn but not DBA/2 mice [Smith, Cabral, Carthew, Francis and Manson (1989) Int. J. Cancer 43, 492-496]. We have investigated the induction of uroporphyria in 12 inbred strains of mice 25 weeks after iron treatment (600 mg/kg) to determine if there was any correlation with the Ah locus. Under these conditions, inhibition of UROD occurred to varying degrees in Ahd mice (SWR and AKR) as well as nominally Ahb-1 (C57BL/6J, C57BL/10ScSn and C57BL/10-cc) and Ahb-2 strains (BALB/c and C3H/HeJ). Five other Ahb or Ahd strains (C57BL/Ks, A/J, CBA/J, LP and DBA/2) were unaffected. Thus there appeared to be no correlation with the Ah phenotype and this illustrated that some other variable inherited factors are involved. Comparisons between another susceptible strain, A2G, and the congenic A2G-hr/+strain (carrying the recessive hr gene) showed a modulating influence associated with the hr locus. In contrast with individual mice of inbred strains, which showed consistent responses to iron, those of the outbred MF1 strain showed a spectrum of sensitivities as might be expected for a heterogeneic stock. The rate of porphyria development was accelerated by administration of 5-aminolaevulinic acid (5-ALA) in the drinking water, but this did not overcome strain differences. Among four strains the order of susceptibility was SWR > C57BL/10ScSn > C57B1/6J > DBA/2 (the last strain was completely resistant). With degrees of iron loading greater than 600 mg of Fe/kg (1200-1800 mg of Fe/kg) C57BL/10ScSn mice (after 20 weeks) and SWR mice (after 5 weeks which included 4 weeks of 5-ALA treatment) had less inhibition of UROD and a lower uroporphyric response, showing that there was an optimum level of liver iron concentration. Studies on selected microsomal enzyme activities associated with cytochrome P-450 showed no correlation with the propensities of strains to develop porphyria. These activities included the NADPH-dependent oxidation of uroporphyrinogen I to uroporphyrin I.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471047      PMCID: PMC1132476          DOI: 10.1042/bj2910029

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

1.  Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.

Authors:  B F Felsher; M L Jones; A G Redeker
Journal:  JAMA       Date:  1973-11-05       Impact factor: 56.272

2.  A simple technique for measuring storage iron concentrations in formalinised liver samples.

Authors:  J D Torrance; T H Bothwell
Journal:  S Afr J Med Sci       Date:  1968-04

3.  Iron storage in porphyria cutanea tarda.

Authors:  O Lundvall; A Weinfeld; P Lundin
Journal:  Acta Med Scand       Date:  1970 Jul-Aug

4.  Induction of hepatic delta-aminolevulinic acid synthetase activity in strains of inbred mice.

Authors:  S R Gross; J J Hutton
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

Review 5.  Experimental porphyria.

Authors:  G D Sweeney
Journal:  Clin Dermatol       Date:  1985 Apr-Jun       Impact factor: 3.541

6.  Experimental porphyrias as models for human hepatic porphyrias.

Authors:  F De Matteis; M Stonard
Journal:  Semin Hematol       Date:  1977-04       Impact factor: 3.851

7.  Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice.

Authors:  A G Smith; J E Francis; P Carthew
Journal:  Carcinogenesis       Date:  1990-03       Impact factor: 4.944

8.  Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron.

Authors:  S K Mukerji; N R Pimstone
Journal:  Arch Biochem Biophys       Date:  1990-09       Impact factor: 4.013

9.  Genetic variance of laboratory outbred Swiss mice.

Authors:  M C Rice; S J O'Brien
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

10.  Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  G D Sweeny; K G Jones; F M Cole; D Basford; F Krestynski
Journal:  Science       Date:  1979-04-20       Impact factor: 47.728

View more
  8 in total

1.  Uroporphyria in the Cyp1a2-/- mouse.

Authors:  John D Phillips; James P Kushner; Hector A Bergonia; Michael R Franklin
Journal:  Blood Cells Mol Dis       Date:  2011-08-30       Impact factor: 3.039

2.  Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.

Authors:  P R Sinclair; N Gorman; T Dalton; H S Walton; W J Bement; J F Sinclair; A G Smith; D W Nebert
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 3.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

Review 4.  Uroporphyrinogen decarboxylase.

Authors:  G H Elder; A G Roberts
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

5.  Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(-/-) mice.

Authors:  Melissa L Barker; Laura B Hathaway; Dorinda D Arch; Mark L Westbroek; James P Kushner; John D Phillips; Michael R Franklin
Journal:  Chem Biol Interact       Date:  2009-09-20       Impact factor: 5.192

6.  A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.

Authors:  John D Phillips; Hector A Bergonia; Christopher A Reilly; Michael R Franklin; James P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

7.  Isolation and characterization of extragenic mutations affecting the expression of the uroporphyrinogen decarboxylase gene (HEM12) in Sacharomyces cerevisiae.

Authors:  T Zoładek; A Chełstowska; R Labbe-Bois; J Rytka
Journal:  Mol Gen Genet       Date:  1995-05-20

8.  A mouse model of familial porphyria cutanea tarda.

Authors:  J D Phillips; L K Jackson; M Bunting; M R Franklin; K R Thomas; J E Levy; N C Andrews; J P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.